Selection of dialysis methods for end-stage kidney disease patients with diabetes
- PMID: 39280188
- PMCID: PMC11372645
- DOI: 10.4239/wjd.v15.i9.1862
Selection of dialysis methods for end-stage kidney disease patients with diabetes
Abstract
The increasing prevalence of diabetes has led to a growing population of end-stage kidney disease (ESKD) patients with diabetes. Currently, kidney transplantation is the best treatment option for ESKD patients; however, it is limited by the lack of donors. Therefore, dialysis has become the standard treatment for ESKD patients. However, the optimal dialysis method for diabetic ESKD patients remains controversial. ESKD patients with diabetes often present with complex conditions and numerous complications. Furthermore, these patients face a high risk of infection and technical failure, are more susceptible to malnutrition, have difficulty establishing vascular access, and experience more frequent blood sugar fluctuations than the general population. Therefore, this article reviews nine critical aspects: Survival rate, glucose metabolism disorder, infectious complications, cardiovascular events, residual renal function, quality of life, economic benefits, malnutrition, and volume load. This study aims to assist clinicians in selecting individualized treatment methods by comparing the advantages and disadvantages of hemodialysis and peritoneal dialysis, thereby improving patients' quality of life and survival rates.
Keywords: Diabetes; Dialysis methods selection; End-stage kidney disease; Hemodialysis; Peritoneal dialysis.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
Similar articles
-
Optimizing dialysis modalities for diabetic end-stage kidney disease: A focus on personalized care and resource-limited settings.World J Diabetes. 2025 Mar 15;16(3):100592. doi: 10.4239/wjd.v16.i3.100592. World J Diabetes. 2025. PMID: 40093289 Free PMC article.
-
What is the optimal dialysis method for diabetic patients with end stage kidney disease?World J Diabetes. 2024 Dec 15;15(12):2272-2275. doi: 10.4239/wjd.v15.i12.2272. World J Diabetes. 2024. PMID: 39676810 Free PMC article.
-
Diabetes mellitus and dialysis.Minerva Urol Nefrol. 2004 Sep;56(3):289-303. Minerva Urol Nefrol. 2004. PMID: 15467507 Review.
-
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56. G Ital Nefrol. 2009. PMID: 19927265 Italian.
-
Renal Replacement Therapy For Elderly Patients with ESKD Through Shared Decision-Making.Electrolyte Blood Press. 2023 Jun;21(1):1-7. doi: 10.5049/EBP.2023.21.1.1. Epub 2023 Jun 27. Electrolyte Blood Press. 2023. PMID: 37434803 Free PMC article. Review.
Cited by
-
The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study.Lipids Health Dis. 2025 Mar 13;24(1):91. doi: 10.1186/s12944-025-02510-z. Lipids Health Dis. 2025. PMID: 40082960 Free PMC article.
-
Enhanced prognostic value of a composite nutritional-inflammatory index (P-CONUT) for predicting mortality risk in patients initiating peritoneal dialysis.PLoS One. 2025 May 22;20(5):e0323318. doi: 10.1371/journal.pone.0323318. eCollection 2025. PLoS One. 2025. PMID: 40403009 Free PMC article.
-
Optimizing dialysis modalities for diabetic end-stage kidney disease: A focus on personalized care and resource-limited settings.World J Diabetes. 2025 Mar 15;16(3):100592. doi: 10.4239/wjd.v16.i3.100592. World J Diabetes. 2025. PMID: 40093289 Free PMC article.
-
What is the optimal dialysis method for diabetic patients with end stage kidney disease?World J Diabetes. 2024 Dec 15;15(12):2272-2275. doi: 10.4239/wjd.v15.i12.2272. World J Diabetes. 2024. PMID: 39676810 Free PMC article.
References
-
- Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. 2021;398:786–802. - PubMed
-
- Kuehn BM. End-stage Kidney Disease Doubles. JAMA. 2022;327:1540. - PubMed
-
- Kleinaki Z, Kapnisi S, Theodorelou-Charitou SA, Nikas IP, Paschou SA. Type 2 diabetes mellitus management in patients with chronic kidney disease: an update. Hormones (Athens) 2020;19:467–476. - PubMed
Publication types
LinkOut - more resources
Full Text Sources